Safety & Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the safety and efficacy of peginesatide for the
treatment of anemia in participants with chronic kidney disease, who are not on dialysis and
not on erythropoiesis stimulating agent (ESA) treatment.